# Rapid Build of HIV Related Protective Barriers

> **NCT03852849** · NA · UNKNOWN · sponsor: **National Center for AIDS/STD Control and Prevention, China CDC** · enrollment: 600 (estimated)

## Conditions studied

- Viral Suppression of HIV Infection

## Interventions

- **BEHAVIORAL:** Personal involved intervention strategies
- **DRUG:** The dosage of 400mg EFV

## Key facts

- **NCT ID:** NCT03852849
- **Lead sponsor:** National Center for AIDS/STD Control and Prevention, China CDC
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-03-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2019-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03852849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03852849, "Rapid Build of HIV Related Protective Barriers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03852849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*